Skin manifestations of COVID-19 in children: Part 3.
Details
Serval ID
serval:BIB_CC27183B0285
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Skin manifestations of COVID-19 in children: Part 3.
Journal
Clinical and experimental dermatology
Working group(s)
ESPD Group for the Skin Manifestations of COVID-19
ISSN
1365-2230 (Electronic)
ISSN-L
0307-6938
Publication state
Published
Issued date
04/2021
Peer-reviewed
Oui
Volume
46
Number
3
Pages
462-472
Language
english
Notes
Publication types: Journal Article ; Review
Publication Status: ppublish
Publication Status: ppublish
Abstract
The current COVID-19 pandemic is caused by the SARS-CoV-2 coronavirus. The initial recognized symptoms were respiratory, sometimes culminating in severe respiratory distress requiring ventilation, and causing death in a percentage of those infected. As time has passed, other symptoms have been recognized. The initial reports of cutaneous manifestations were from Italian dermatologists, probably because Italy was the first European country to be heavily affected by the pandemic. The overall clinical presentation, course and outcome of SARS-CoV-2 infection in children differ from those in adults as do the cutaneous manifestations of childhood. In this review, we summarize the current knowledge on the cutaneous manifestations of COVID-19 in children after thorough and critical review of articles published in the literature and from the personal experience of a large panel of paediatric dermatologists in Europe. In Part 1, we discuss one of the first and most widespread cutaneous manifestations of COVID-19, chilblain-like lesions, and in Part 2 we expanded to other manifestations, including erythema multiforme, urticaria and Kawasaki disease-like inflammatory multisystemic syndrome. In this part of the review, we discuss the histological findings of COVID-19 manifestations, and the testing and management of infected children for both COVID-19 and any other pre-existing conditions.
Keywords
Adolescent, Antibodies, Monoclonal, Humanized/therapeutic use, COVID-19/complications, COVID-19/diagnosis, COVID-19/pathology, COVID-19 Testing, Child, Dermatologic Agents/therapeutic use, Exanthema/drug therapy, Exanthema/pathology, Exanthema/virology, Humans, Nicolau Syndrome/drug therapy, Nicolau Syndrome/pathology, Nicolau Syndrome/virology, Pityriasis Rosea/pathology, Pityriasis Rosea/virology, Purpura/drug therapy, Purpura/pathology, Purpura/virology, SARS-CoV-2, Skin Diseases, Viral/drug therapy, Skin Diseases, Viral/pathology, Urticaria/drug therapy, Urticaria/pathology, Urticaria/virology
Pubmed
Web of science
Open Access
Yes
Create date
23/11/2020 14:15
Last modification date
06/01/2024 8:12